The body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), Hemoglobin A1c (HbA1c), serum glucose, total protein, albumin, triglyceride (TG), low-density lipoprotein cholesterol (LDL-c), AST, ALT, and γ-glutamyl transpeptidase (γGT) levels were significantly higher in NAFLD subjects than in normal subjects. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.